InvestorsHub Logo

Rocky3

05/24/15 5:16 PM

#13714 RE: DewDiligence #13695

The sales projections on page 6 of the presentation show very low sales in 2020 for biosimilars - maybe $200M covering both biosimilars. Not very high and pretty disappointing for MNTA if accurate.